Investor insights
Sectors invested in
Pharmaceutical1
内分泌1
Biotechnology1
Life Science1
Funding rounds participated in
$40M sweet spot round size
Most of their 1 investments are in rounds between $40M and $40M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Innovation
Health Care
Globalization
TransCon Technology
Oncology
Drug Development
Ophthalmology
Clinical Trials
Endocrinology
Date founded
2007
Investments made
维
维昇药业 raised $40M on November 13, 2018
Investors: Sofinnova Ventures, Russia technology fund, Vivo Capital and Ascendis Pharma
Funding rounds raised
Total raised
$150M
from 10 investors over 10 rounds
A
Ascendis Pharma raised $150M on September 5, 2023
Investors: Royalty Pharma
A
Ascendis Pharma raised undisclosed on January 1, 2017
Investors: Sofinnova Ventures, Russia technology fund
A
Ascendis Pharma raised $60M on December 1, 2014
Investors: RA Capital Management, L.P., Venrock, Vivo Capital, Sofinnova Ventures, Russia technology fund and OrbiMed Advisors
A
Ascendis Pharma raised $26M on December 13, 2007
Investors: Technostart Gmbh, Gilde Healthcare and Sofinnova Partners